MicroPulse TLT for Glaucoma Management in a Comprehensive Practice

Show Description +

Shahed Y Ghoghawala, MD, from South Texas Eye Consultants in Corpus Christi, Texas explains the Evolution & Expectations of MicroPulse Transscleral Laser Therapy for Glaucoma Management in a Comprehensive Practice.

Posted: 8/29/2023

Keywords:

Glaucoma

Glaucoma

MicroPulse TLT

IRIDEX

Up Next

MicroPulse TLT Consensus: Panel Discussion (Part 1)

Jella An, MD, MBA (Wilmer Eye Institute) Jacob Brubaker, MD (Sacramento Eye Consultants) Ronald M.P.C. de Crom, MD (University Eye Clinic Maastricht) Brian A. Francis, MD, MS (Doheny Eye Institute) Michael C. Giovingo, MD (Cook County Health) Tomás M. Grippo, MD (Grippo Glaucoma and Cataract Center) Brian Jerkins, MD (UT Hamilton Eye Institute) Robert J. Noecker, MD, MBA (OCLI Vision; Yale University) Nathan M. Radcliffe, MD (New York Eye Surgery Center) Marc Töteberg-Harms, MD (USZ Zurich)


Glaucoma

MicroPulse TLT Consensus: Panel Discussion (Part 1)

Jella An, MD, MBA (Wilmer Eye Institute) Jacob Brubaker, MD (Sacramento Eye Consultants) Ronald M.P.C. de Crom, MD (University Eye Clinic Maastricht) Brian A. Francis, MD, MS (Doheny Eye Institute) Michael C. Giovingo, MD (Cook County Health) Tomás M. Grippo, MD (Grippo Glaucoma and Cataract Center) Brian Jerkins, MD (UT Hamilton Eye Institute) Robert J. Noecker, MD, MBA (OCLI Vision; Yale University) Nathan M. Radcliffe, MD (New York Eye Surgery Center) Marc Töteberg-Harms, MD (USZ Zurich)

MicroPulse TLT Consensus: Panel Discussion (Part 2)

Jella An, MD, MBA (Wilmer Eye Institute) Jacob Brubaker, MD (Sacramento Eye Consultants) Ronald M.P.C. de Crom, MD (University Eye Clinic Maastricht) Brian A. Francis, MD, MS (Doheny Eye Institute) Michael C. Giovingo, MD (Cook County Health) Tomás M. Grippo, MD (Grippo Glaucoma and Cataract Center) Brian Jerkins, MD (UT Hamilton Eye Institute) Robert J. Noecker, MD, MBA (OCLI Vision; Yale University) Nathan M. Radcliffe, MD (New York Eye Surgery Center) Marc Töteberg-Harms, MD (USZ Zurich)

When to treat glaucoma with MicroPulse TLT and when to treat with Continuous Wave TSCPC

Mahmoud A. Khaimi, MD Richard Lee, MD Robert Noecker, MD, and Nir Shoham-Hazo, MD

MicroPulse Transscleral Laser Therapy in Combination With Other Glaucoma Treatments

Courtney Bovee, MD, Sebastian Heersink, MD, Rajen Desai, MD

MicroPulse Transscleral Laser Therapy before incisional glaucoma procedures

Michael Giovingo, MD Mona Kaleem, and MD Ahad Mahootchi, MD

Retina

The Management of AMD, CSR, and DME with MicroPulse Laser Therapy

Jorge Calzada, MD, Brian Horsman, MD, and Glenn Yiu, MD

EURETINA Symposium 2022: MicroPulse® and PASCAL® in the world of retinal treatments

Stela Vujosevic, MD, Edoardo Midena, MD, Boris Stanzel, MD, and Paulo-Eduardo Stanga, MD

Macular Laser Therapy: A closer look at the Pascal Laser with Endpoint Management

Victor Gonzalez, MD, Yannis Paulus, MD, and Francisco Rodríguez, MD

Reducing the Burden of Injection Therapy with MicroPulse Laser

Roger Goldberg, MD, MBA, Shawn C. Kavoussi, MD, and Caesar Luo, MD, FACS

MicroPulse Laser for Diabetic Macular Edema and Retinal Vein Occlusion: Best Practices

Boris Stanzel, MD, Stela Vujosevic, MD, and Edoardo Midena, MD

MicroPulse TLT for Glaucoma Management in a Comprehensive Practice

Shahed Y Ghoghawala, MD, from South Texas Eye Consultants in Corpus Christi, Texas explains the Evolution & Expectations of MicroPulse Transscleral Laser Therapy for Glaucoma Management in a Comprehensive Practice.

Posted: 8/29/2023

Keywords:

Glaucoma

Glaucoma

MicroPulse TLT

IRIDEX

Resources

Treat and Extend with PASCAL Laser

View Resource

DIAMONDS: A Randomized Controlled Trial Designed with Patients in Mind

Read on Retina Today

The Clinical and Economic Argument for MicroPulse® Laser in a Retinal Practice

Read on Retina Today

Comprehensive Ophthalmologists Discuss Practice Benefits of Transscleral Laser Therapy (TLT) with MicroPulse® Technology for a Broad Range of Glaucoma Patients

Read on Glaucoma Today

MicroPulse® Transscleral Laser Therapy for the Treatment of Glaucoma: Guidelines from an International Delphi Panel

Read on Glaucoma Today

About Iridex

Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems for the ophthalmology market. The Company’s proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME), and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors.